AMBEV S.A. (ABEV): what the price assumes

boothcheck covers AMBEV S.A. (ABEV) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-08-07.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/ABEV

Headline

FieldValue
TickerABEV
CompanyAMBEV S.A.
Sector / IndustryConsumer Defensive
Current price$2.87/sh
CompositionBrazil 56% / CAC (Central America and the Caribbean) 12% / Latin America - South 20% / Canada 12%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)8.4%
Operating margin today26.4%
Margin compression (value-band)-18.0pp
Multiple paid9x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 8.6% cost of capital with 4% terminal growth over a 5-year stage.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-1.29σ
cohort percentile (of 69 peers)4

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.03x5expensive
Earnings1.16x4expensive
Relative0.88x5justifies
Growth0.87x3justifies

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.0%); the inversion above states its own rate.

Per-Model Detail (n=17)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$5.100.56xyesFCF base $3.9B, growth 5% (input: historical growth), terminal g 4.0%, WACC 9.0%, 5yr projection
DCF Exit MultipleGrowth$3.300.87xyesExit EV/EBITDA: 7.6x / 9.6x / 11.6x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$4.390.65xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.5x / 22.0x / 25.5x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$2.151.33xyesBV/sh $1.10, ROE (TTM) 18.0%, ke 9.3%
Two-Stage Excess ReturnAsset$2.960.97xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$2.181.32xyesRev $25.8B, growth 5% (input: historical growth; tapered), Terminal P/S: 1.5x / 1.8x / 2.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$2.341.23xyesEPS $0.19, growth 6% (input: historical EPS growth), PEG=2.61 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$2.251.28xyesNormalized EBIT (5y avg op income, one-time charges added back) $3.87B × (1−21%) / WACC 9.0% → EPV (no growth)
Residual IncomeAsset$2.940.98xyesBV $1.10 + 5yr PV of (ROE (TTM) 18.0% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$2.201.30xyes√(22.5 × EPS $0.19 × BVPS $1.10) — Graham's conservative floor
EV/EBITDA RelativeRelative$4.160.69xyesEBITDA $4.57B × sector EV/EBITDA 14.0x
FCF YieldEarnings$2.771.04xyesFCF $3894.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$3.190.90xyesEPS $0.19 × (8.5 + 2×5.5%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$2.791.03xyesBV $1.10 × (ROIC 22.8% / WACC 9.0%)
P/Sales SectorRelative$3.270.88xyesRevenue $25.76B × sector P/S 2.0x
PEG Fair ValueRelative$1.621.77xyesEPS $0.19 × (PEG 1.5 × growth 5.5% (input: historical EPS growth)) → PE 8.3x
Earnings YieldEarnings$2.101.37xyesEPS $0.19 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$3.3b
Net debt / NOPAT (after-tax)-0.92x (net cash)
Net debt / operating income (pre-tax)-0.73x (net cash)
Interest coverage5.3x
Share count CAGR (buyback)-0.2%
Burning cashno

Bullet Takeaways

Bull Case

Very few consumer businesses of this size earn what Ambev earns. In 2025 the company reported income from operations of 23,317.7 million reais on net sales of 88,242.5 million, an operating margin of 26.4%, up from 21,801.7 million of operating profit the year before. Note the direction: net sales in reais fell slightly, and operating profit still rose 7%. That combination only happens when the business controls its own pricing and its own route to the customer.

The structural advantage is distribution, not brand alone. In Brazil the company owns the trucks, the coolers, the returnable bottle pool and the relationships with hundreds of thousands of small bars and shops, which is why a competitor with a good brand and a good product still has to rent access to the shelf. The filing shows what the alternative looks like: in markets where Ambev does not own the route, it says so plainly. Our main competitor in Guatemala is Cerveceria Centro Americana, the market leader, which is a private company owned by local investors. Ambev sells there through a third-party bottler's network, and it is the challenger. Where it owns the network, it is not.

The returns follow the structure. Gross profit ran 45,378.4 million reais in 2025, better than half of net sales, and the business converts that into cash quickly because retailers pay fast and inventory turns in weeks. Second-quarter 2026 cash flow from operating activities was 4,711.4 million reais, up 54.5% from 3,050.0 million a year earlier, helped by working capital. Against that, borrowings are almost an afterthought. The company finished 2025 with 18,638.2 million reais of cash and equivalents plus 1,681.7 million of current investment securities, against non-current interest-bearing loans of 2,219.6 million. Very few businesses in any sector operate with that little claim on their own earnings.

The non-alcoholic side is an underappreciated second engine. Ambev bottles Pepsi across much of Latin America and competes head-on with the obvious incumbent: Our main competitor in the NAB market is The Coca-Cola Company. Brazilian non-alcoholic net sales reached 8,800.1 million reais in 2025, up 4.9%, on 8.3% higher revenue per hectoliter against a 3.1% volume decline. That is a business raising prices faster than it loses cases, which is what pricing power looks like from the inside.

Momentum in the current year is real and it is broad. Second-quarter 2026 net revenue grew 6.1% organically with revenue per hectoliter up 4.6%, every business unit grew net revenue, and the company's normalized operating profit measure rose 8.9% with its margin widening 80 basis points to 31.6%. Beer volumes in Brazil, the segment that carries 56% of the company, grew 5.0%. For a business the market treats as ex-growth, that is a lot of growth.

Bear Case

The uncomfortable observation about Ambev is that it has been visibly cheap for a long time and has stayed that way, and the market has had a reason. The reason is that the profits are earned in reais, Argentine pesos, Dominican pesos and Canadian dollars, and the shareholder is paid in none of those. In 2025 the company earned 15,988.4 million reais of net income. After translating its foreign operations, total comprehensive income was 6,140.8 million, with translation losses of 9,055.9 million doing the damage. More than half of a very good operating year disappeared into an exchange rate. The 20-F says it directly: Our results of operations are affected by changes in the exchange rates of the real against the U.S. dollar.

The second problem is that the underlying business is growing in price, not in cases. Net sales in reais fell to 88,242.5 million in 2025 from 89,452.7 million in 2024. Brazilian non-alcoholic volumes fell 3.1% for the year and another 4.4% in the second quarter of 2026, while Latin America South fell 2.9% and Canada fell 1.8% in the same quarter. Revenue per hectoliter is doing the work. In a category where consumption per person is broadly flat and the consumer is stretched, there is a ceiling on how long price can substitute for volume, and nobody knows where it is until it is passed.

Tax is the third exposure, and it is the one that can move a whole year. Ambev's risk factors put it first among regulatory concerns: Increases in taxes levied on beverage products in the countries in which we operate and unfair competition arising from tax evasion may adversely affect our results and profitability. Brazilian beverage taxation is being rewritten, and the sums involved are large enough that the gap between what the company charges and what it keeps is set in Brasilia rather than in a boardroom.

Look closely at the balance sheet that the bull case leans on and part of it is not really there. Total equity at the end of 2025 was 88,774.8 million reais, of which goodwill accounted for 41,538.4 million and other intangibles 11,042.7 million. Roughly three fifths of the stated equity is the accounting residue of past acquisitions rather than assets that could be sold. Meanwhile the cumulative currency adjustment sitting against equity reached negative 78,364.5 million reais, which is the accumulated record of exactly the erosion described above.

The bull is right that the operating business is excellent and that the cash is real. The bear case is not that the shares are expensive, because no standard approach says they are. It is that a business earning consistently high returns in currencies that consistently weaken can look permanently cheap in dollars without ever paying the holder for the discount. The market is not mispricing the beer. It is pricing the currency, the tax regime and the political calendar, and those have not resolved.

Valuation

The starting point here is unusual for a large consumer name: there is no growth assumption to interrogate. Today's price sits below what the business would be worth even if operating profit declined steadily from here, worked out against an 8.7% cost of capital and 4% terminal growth over a five-year stage. That is a bound rather than a forecast, and it means the argument is not about whether Ambev can compound. It is about whether the earnings it already produces are worth what earnings of that quality normally fetch.

The methods agree with each other to an unusual degree, which is itself the signal. The earnings-power approaches, which capitalize demonstrated profit with no growth at all, put the price roughly a fifth above where they land. The book-value-plus-profitability approaches sit essentially level with it. Nothing in the standard toolkit reads this as a growth bet. When every family of method clusters this tightly around the quote, the price is not carrying an expectation the fundamentals have to grow into. It is carrying a discount for something the fundamentals do not describe.

What has to be true is therefore modest. Operating profit of 23,317.7 million reais for the year ended December 31, 2025, on net sales of 88,242.5 million, would need to hold roughly where it is rather than expand. The 2025 result was already up on 21,801.7 million in 2024 and 18,831.0 million in 2023. Three consecutive years of higher operating profit is not the profile of a business that needs a rescue.

Cohort position confirms the profitability without flattering it. Among its whole-company comparable set, only STZ at 29.9% and MNST at 29.3% convert more of each revenue dollar into operating profit than Ambev's 26.4%, and both of those are growing revenue in a currency that does not move against the buyer. KDP converts 20.8%. TAP, the closest structural analogue in beer, is currently reporting a negative operating result. Ambev is at the strong end of a cohort that is mostly struggling.

Solvency removes the usual downside amplifier entirely. Cash and equivalents of 18,638.2 million reais at year end against non-current interest-bearing loans of 2,219.6 million leaves the company owing very little to anyone, and finance expenses of 4,410.7 million were covered several times over by operating profit. Those finance expenses are mostly not interest on borrowings; they reflect monetary and hedging items typical of a Brazilian filer. The practical consequence is that Ambev never has to sell anything at a bad moment, which is precisely why the discount in the price has to be explained by currency and policy rather than by the business.

Catalysts

Second-quarter 2026 results, released July 30, 2026, showed the operating story intact. Consolidated volumes rose 1.4% organically, net revenue rose 6.1% on 4.6% higher revenue per hectoliter, and every business unit grew net revenue. The company's normalized operating profit measure rose 8.9% with margin widening 80 basis points to 31.6%, and its normalized profit measure reached 3,492.7 million reais against 2,832.7 million a year earlier, an increase of 23.3% helped by lower net financial expenses. Cash flow from operating activities of 4,711.4 million reais was up 54.5% year over year.

Distributions are scheduled and sizeable. The board approved on July 29, 2026 the payment date of October 6, 2026 for the third and final tranche of interest on capital declared in December 2025, worth 1.9 billion reais before withholding tax, together with a new distribution of approximately 1.1 billion reais before withholding tax to be paid by December 2026. Brazilian interest on capital is deductible to the payer, which is why the company uses it in preference to an ordinary dividend, and it reaches ADS holders only after conversion into dollars.

The variables that will actually move the year are outside the operating business. The direction of the real against the dollar determines how much of the reported profit reaches a dollar holder, and 2025 showed how large that gap can get. Brazilian beverage tax reform remains unresolved, and the company lists tax increases first among the regulatory risks it faces. Argentina remains under hyperinflation accounting, and for fiscal 2026 the company amended its own definition of organic revenue growth to cap Argentine price growth at 2% per month, which changes how the headline growth rates should be read.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

FY2025 Form 20-F · 2Q26 results release, July 30, 2026 · FY2025 Form 20-F, consolidated balance sheet · FY2025 Form 20-F risk factors

View the full interactive ABEV report on boothcheck